Back
SpringWorks Therapeutics Stock Price Chart
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free
Sell
9
SWTX
SpringWorks Therapeutics
Last Price:
$32.50
Seasonality Move:
-2.03%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.
SpringWorks Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.42 | Sell |
| 20-day SMA: | 37.4 | Sell |
| 50-day SMA: | 37.33 | Sell |
| 200-day SMA: | 38.27 | Sell |
| 8-day EMA: | 37.61 | Sell |
| 20-day EMA: | 37.86 | Sell |
| 50-day EMA: | 37.24 | Sell |
| 200-day EMA: | 37 | Sell |
SpringWorks Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 37.1 | Sell |
| Chaikin Money Flow: | -2546118 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.59 - 40.53) | Sell |
| Bollinger Bands (100): | (31.91 - 40.11) | Sell |
SpringWorks Therapeutics Technical Analysis
| Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 32.50 while SWTX 8-day simple moving average is 38.42, which is a Sell signal.
-
The stock price of SWTX is 32.50 while SpringWorks Therapeutics 20-day SMA is 37.40, which makes it a Sell.
-
SpringWorks Therapeutics 50-day simple moving average is 37.33 while SWTX share price is 32.50, making it a Sell technically.
-
SWTX stock price is 32.50 and SpringWorks Therapeutics 200-day simple moving average is 38.27, creating a Sell signal.
SWTX Technical Analysis vs Fundamental Analysis
Sell
9
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a SellThe current SpringWorks Therapeutics [SWTX] share price is $32.50. The Score for SWTX is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
2.4B
Price in USD:
32.50
Share Volume:
2.7M
SpringWorks Therapeutics 52-Week Range
52-Week High:
53.92
52-Week Low:
28.21
Sell
9
SpringWorks Therapeutics (SWTX)
is a Sell
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?The SpringWorks Therapeutics stock price is 32.50 USD today.
-
Will SWTX stock go up or go down?SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is SpringWorks Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is overvalued.
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 32.50 while SWTX 8-day exponential moving average is 37.61, which is a Sell signal.
-
The stock price of SWTX is 32.50 while SpringWorks Therapeutics 20-day EMA is 37.86, which makes it a Sell.
-
SpringWorks Therapeutics 50-day exponential moving average is 37.24 while SWTX share price is 32.50, making it a Sell technically.
-
SWTX stock price is 32.50 and SpringWorks Therapeutics 200-day simple moving average is 37.00, creating a Sell signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.12 per share, and an increase next year of $1.33 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
-
SWTX Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting SpringWorks Therapeutics is a Sell
-
SpringWorks Therapeutics Relative Strength Index (RSI) is 37.1, which suggest SpringWorks Therapeutics is oversold
-
The Bollinger Bands (25) for SpringWorks Therapeutics is (35.59 - 40.53), which suggest SpringWorks Therapeutics is a Sell
-
The Bollinger Bands (100) for SpringWorks Therapeutics is (31.91 - 40.11), which suggest SpringWorks Therapeutics is a Sell
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.